BioMimetic Therapeutics, Inc. news

   Watch this stock
Showing stories 1 - 10 of about 17   

Articles published

BMTI 0.0000
price chart
Zimmer purchases biologic therapeutics company ETEX
"Zimmer is committed to developing the most comprehensive range of biologic therapies for patients suffering from musculoskeletal joint disease, from early intervention solutions like Gel-One Cross-linked Hyaluronate and joint preservation solutions ...
Related articles »  
ReWalk Robotics Prices IPO BY ANDREW VAHRADIAN, SEPTEMBER 22, 2014
ReWalk Robotics is medical device company that develops exoskeletons, devices that provide wheelchair-bound individuals with mobility impairments or other medical conditions, the ability to stand and walk once again.
Blackstone to Acquire Stake in Xinrong Best Medical Instrument for $100M BY ...
Furthermore, the company is aiming to be more competitive on implant pricing than multinational medical device manufacturers operating in the country.
Related articles »  
Frost & Sullivan Confers Technology Innovation Leadership Award on ADOCIA ...
"The company constantly strategizes to boost the suitability and ease of use of BioChaperone´┐Ż so as to make the therapeutic proteins in the market accessible to the masses." ... In its pursuit to increase the drug uptake by cancerous cells, the company ...
Related articles »  
LENSAR Appoints Charlie Federico and Carmen Bringgold to Board of Directors
... including Board Chairman, Compensation and Governance Committee Chairman and member of the Audit Committee of MAKO Surgical Corp (acquired by Stryker in 2013 for $1.65 billion), as well as similar roles BioMimetic Therapeutics Inc. (acquired by ...
Related articles »  
Aethlon Medical Receives Notice of DARPA Contract Renewal
22, 2014 /PRNewswire/ -- Aethlon Medical, Inc. (OTCQB: AEMD), the pioneer in developing targeted therapeutic devices to address infectious disease, cancer and other life-threatening conditions, disclosed today that the Defense Advanced Research ...
Related articles »  
Open Access Week Explores Business & Management Sciences from Global ...
OMICS Publishing House takes pleasure in inviting authors, researchers, academicians and practitioners to contribute generously to its Business and Management Group Journals on the eve of 'Open Access Week' from 20th October to 26th October, 2014.
Related articles »  
Pharma and Omics Journals to Address Global Challenges during Open Access ...
OMICS Group International invites researchers, authors and academicians across the globe to participate in the 'Open Access Week' by actively contributing their research outcome as articles to OMICS Group Pharma and Omics Journals from 20-26th ...
Related articles »  
Chemistry for Global Development during the Open Access Week
OMICS Group International invites researchers, authors and academicians across the globe to participate in the 'Open Access Week' by actively contributing their research outcome as articles to OMICS Group Chemistry Journals from 20-26th October, 2014.
Related articles »  
Share the Cutting Edge Research Updates on Life Sciences and Environmental ...
OMICS Group International invites researchers, authors and academicians across the globe to participate in the 'Open Access Week' by actively contributing their research outcome as articles to OMICS Group Life Science and Environmental Journals from ...
Related articles »